Trademarkia Logo

Canada

C$
Trademark Search in Canada
MOPED

View On IC.GC.CA

MOPED
SEARCHED

on 3 Sept 2024

Last Applicant/ Owned by

ONCOPIA THERAPEUTICS INC.

151 West 42nd Street, 15th FloorNew York NY 10036

US

Serial Number

2261186 filed on 15th Mar 2023

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

MOPED

Trademark usage description

downloadable computer software for use in the field of drug discovery, screenings, and pharmaceuticals; downloadable computer software for use to diag Read More

Classification Information

Class [009]
Downloadable computer software for use in the field of drug discovery, screenings, and pharmaceuticals; downloadable computer software for use to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable computer software for use in collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry, clinical trial management and patient engagement.

Classification kind code

12

Class [042]
Drug discovery services; DNA and protein screening for scientific research purposes; platform as a service (PAAS) featuring computer software platforms for use in the field of drug discovery, screenings, and pharmaceuticals; scientific and technological services and research and design relating thereto; analysis of technical data by computers; pharmaceutical drug discovery services; pharmaceutical and biotechnology research and development services; drug use discovery services; design and development of pharmaceutical preparations and medicines; research and development in the field of drug discovery; conducting scientific and pharmaceutical research and data analysis to screen for and identify molecular interactions, compounds and detect toxicity; providing scientific, pharmaceutical and agrochemical database research services; scientific and pharmaceutical artificial intelligence research services to identify molecules and compounds for drug discovery and chemical development; bioinformatics services, namely, using the combination of biology, computer science, information engineering, mathematics and statistics to analyze and interpret biological data; computer assisted molecule design; identification of biological targets, networks and pathways; biological research and analysis; pharmaceutical research and development services; computer aided diagnostic and screening services for scientific research purposes; contract research services in support of scientific research and development of pharmaceutical preparations; software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of drug discovery and development, genetics, genomics, biology, biochemistry; software as a service for collecting, analyzing, reporting, and tracking data and information in the fields of clinical trial management and patient engagement.

Classification kind code

12

Mark Details

Serial Number

2261186

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 48
on 11th Sept 2024		Agent Changed
Submitted for opposition 22
on 3rd Sept 2024		Search Recorded
Submitted for opposition 20
on 3rd Sept 2024		Examiner's First Report
Submitted for opposition 223
on 3rd Sept 2024		Total Provisional Refusal
Submitted for opposition 256
on 1st Apr 2024		Notification of Possible Opposition Sent
Submitted for opposition 257
on 1st Jun 2023		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 31st May 2023		Formalized
Submitted for opposition 1
on 31st May 2023		Created
Submitted for opposition 228
on 15th Mar 2023		International Registration
Submitted for opposition 30
on 15th Mar 2023		Filed